BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15520781)

  • 1. Variability of markers of inflammation and infection in induced sputum in children with cystic fibrosis.
    Ordoñez CL; Kartashov AI; Wohl ME
    J Pediatr; 2004 Nov; 145(5):689-92. PubMed ID: 15520781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis.
    Sagel SD; Sontag MK; Wagener JS; Kapsner RK; Osberg I; Accurso FJ
    J Pediatr; 2002 Dec; 141(6):811-7. PubMed ID: 12461498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
    Sagel SD; Kapsner RK; Osberg I
    Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced sputum in cystic fibrosis: within-week reproducibility of inflammatory markers.
    Smountas AA; Lands LC; Mohammed SR; Grey V
    Clin Biochem; 2004 Nov; 37(11):1031-6. PubMed ID: 15498533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolastin aerosol therapy and sputum taurine in cystic fibrosis.
    Cantin AM; Berthiaume Y; Cloutier D; Martel M
    Clin Invest Med; 2006 Aug; 29(4):201-7. PubMed ID: 16986483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and use of sputum induction in children with cystic fibrosis.
    Suri R; Marshall LJ; Wallis C; Metcalfe C; Shute JK; Bush A
    Pediatr Pulmonol; 2003 Apr; 35(4):309-13. PubMed ID: 12629630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction.
    Sagel SD; Kapsner R; Osberg I; Sontag MK; Accurso FJ
    Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1425-31. PubMed ID: 11704590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease.
    Moss RB; Mayer-Hamblett N; Wagener J; Daines C; Hale K; Ahrens R; Gibson RL; Anderson P; Retsch-Bogart G; Nasr SZ; Noth I; Waltz D; Zeitlin P; Ramsey B; Starko K
    Pediatr Pulmonol; 2005 Mar; 39(3):209-18. PubMed ID: 15573395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects.
    Sloane AJ; Lindner RA; Prasad SS; Sebastian LT; Pedersen SK; Robinson M; Bye PT; Nielson DW; Harry JL
    Am J Respir Crit Care Med; 2005 Dec; 172(11):1416-26. PubMed ID: 16166615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients.
    Hansen CR; Pressler T; Nielsen KG; Jensen PØ; Bjarnsholt T; Høiby N
    J Cyst Fibros; 2010 Jan; 9(1):51-8. PubMed ID: 19939747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant human DNase on alpha1-proteinase inhibitor function: an experimental approach to the combined clinical use of rhDNase and alpha1-PI in CF patients.
    Hansen G; Hoffjan S; Mosler K; Schuster A
    Lung; 2001; 179(3):185-94. PubMed ID: 11891608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis.
    Martin SL; Downey D; Bilton D; Keogan MT; Edgar J; Elborn JS;
    Pediatr Pulmonol; 2006 Feb; 41(2):177-83. PubMed ID: 16372352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis.
    Ordoñez CL; Henig NR; Mayer-Hamblett N; Accurso FJ; Burns JL; Chmiel JF; Daines CL; Gibson RL; McNamara S; Retsch-Bogart GZ; Zeitlin PL; Aitken ML
    Am J Respir Crit Care Med; 2003 Dec; 168(12):1471-5. PubMed ID: 12969869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced sputum in the very young: a new key to infection and inflammation.
    Mussaffi H; Fireman EM; Mei-Zahav M; Prais D; Blau H
    Chest; 2008 Jan; 133(1):176-82. PubMed ID: 17989149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections.
    Bodini A; D'Orazio C; Peroni D; Corradi M; Folesani G; Baraldi E; Assael BM; Boner A; Piacentini GL
    Pediatr Pulmonol; 2005 Dec; 40(6):494-9. PubMed ID: 16229003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of neutrophil elastase in CF sputum by L-658,758.
    Rees DD; Brain JD; Wohl ME; Humes JL; Mumford RA
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1201-6. PubMed ID: 9399994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis.
    Guyot N; Butler MW; McNally P; Weldon S; Greene CM; Levine RL; O'Neill SJ; Taggart CC; McElvaney NG
    J Biol Chem; 2008 Nov; 283(47):32377-85. PubMed ID: 18799464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between pulmonary function and sputum biomarkers in cystic fibrosis.
    Mayer-Hamblett N; Aitken ML; Accurso FJ; Kronmal RA; Konstan MW; Burns JL; Sagel SD; Ramsey BW
    Am J Respir Crit Care Med; 2007 Apr; 175(8):822-8. PubMed ID: 17234902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on Sagel et al.
    Ren CL
    Pediatr Pulmonol; 2005 Sep; 40(3):275; author reply 276. PubMed ID: 16037925
    [No Abstract]   [Full Text] [Related]  

  • 20. Neutrophil collagenase in sputum from patients with cystic fibrosis.
    Power C; O'Connor CM; MacFarlane D; O'Mahoney S; Gaffney K; Hayes J; FitzGerald MX
    Am J Respir Crit Care Med; 1994 Sep; 150(3):818-22. PubMed ID: 8087357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.